impact factor
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER8400Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice20.00 €
 Subtotal 20.00 €